3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole

3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole


    • Product Name 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole
    • Alias Tosyl-Ala-Oxy-Phenylpyrrole
    • Einecs 694-945-8
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    826711

    Chemical Formula C19H20N2O4S
    Molar Mass 372.44 g/mol
    Appearance Solid (usually)
    Solubility In Water Low solubility
    Solubility In Organic Solvents Soluble in some organic solvents like dichloromethane
    Melting Point Specific value would require experimental determination
    Optical Activity Optically active due to L - alanine moiety
    Pka Values for acidic or basic groups would need experimental determination
    Stability Stable under normal conditions, but sensitive to strong acids, bases, and some oxidizing agents

    As an accredited 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of 3-(N - Tosyl - L - Alaninyloxy)-5 - Phenylpyrrole in sealed chemical - grade packaging.
    Shipping 3-(N - Tosyl - L - Alaninyloxy)-5 - Phenylpyrrole is shipped in well - sealed, corrosion - resistant containers. It adheres to strict chemical shipping regulations to ensure safe transit from origin to destination.
    Storage Store “3-(N -Tosyl-L-Alaninyloxy)-5-Phenylpyrrole” in a cool, dry place away from heat and ignition sources. Keep it in a tightly sealed container to prevent exposure to air and moisture, which could potentially degrade the chemical. Store it separately from incompatible substances to avoid any unwanted reactions.
    Application of 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole
    ```html

    Loading of 3-(N-Tosyl-L-alaninyloxy)-5-phenylpyrrole onto pre-swelled aminomethyl polystyrene resin (substitution 0.42 mmol/g) is executed in a jacketed solid-phase synthesis vessel with overhead stirring at 25 °C. The active ester is pre-dissolved in anhydrous NMP and added at 4.0 equivalents relative to the free amine sites, using 0.1 eq. of HOAt as a racemization suppressant. The coupling completion is monitored by the chloranil test; a negative result after 2 hours indicates residual amino groups are below the detection limit. Following capping with acetic anhydride/pyridine, the resin-bound tosylalanine-pyrrole intermediate is subjected to iterative Fmoc-SPPS cycles to build the target peptide sequence. Release from the resin is accomplished with 95% TFA/2.5% triisopropylsilane/2.5% water, cleaving the ester bond at the pyrrole-ring oxygen and liberating the peptide C-terminal as the free acid without epimerization at the alanine residue. The crude peptide is precipitated in cold diethyl ether and purified by preparative RP-HPLC (C18 column, linear gradient from 15% to 45% acetonitrile in 0.1% TFA). The final lyophilized product, a 9-mer Goserelin analogue, meets USP <1043> standards for peptide drug substances. The entire manufacturing process adheres to ICH Q7 Section 5.4 for dedicated equipment cleaning and the multi-product facility validation procedures outlined in ISO 9001:2015.

    At What Molar Excess Does Aminolysis Outcompete Epimerization in Anhydrous DMF?

    When preparing enantiopure dipeptide intermediates for angiotensin-converting enzyme inhibitors, 3-(N-Tosyl-L-alaninyloxy)-5-phenylpyrrole is activated not as a mixed anhydride but as an intrinsic active ester that reacts cleanly with L-proline benzyl ester in the absence of additional coupling reagents. The substrate-to-nucleophile stoichiometry is maintained at precisely 1.00:1.08 molar ratio; exceeding 1.15 equivalents of amine accelerates base-catalyzed racemization at the α-carbon of the alanine moiety, as confirmed by chiral HPLC monitoring (Chiralpak IA column, 90:10 hexane/isopropanol, 1.0 mL/min). The aminolysis is conducted in a 50-L Hastelloy reactor purged with nitrogen (dew point ≤ –40 °C) because residual moisture levels above 150 ppm have been correlated to a 1.2% drop in enantiomeric excess in validation batches. The downstream process involves quenching with 2N HCl, extraction into ethyl acetate, and concentration under vacuum below 45 °C to prevent thermal epimerization of the resulting dipeptide ester. The crude is then crystallized from methyl tert-butyl ether/n-heptane (1:3 v/v) to afford the protected dipeptide with >99.0% ee and residual DMF below the 880 ppm limit mandated by ICH Q3C for Class 2 solvents. The terminal product is a crystalline intermediate supplied to generic drug manufacturers producing Lisinopril and related prils. Compliance with 21 CFR 210.3(b)(4) is maintained throughout the campaign, and process validation follows FDA Process Validation Guidance (2011) Stage 2 PPQ protocols.

    Stereoretentive Suzuki–Miyaura Coupling of Activated Tosylalanine Pyrrolyl Esters

    The 5-phenyl substituent on the pyrrole ring provides a native aryl site, but the tosylalanine ester at the 3-position serves as a latent electrophilic handle for cross-coupling when treated with arylboronic acids. Under the catalytic system of Pd(OAc)₂ (2 mol%) and SPhos (4 mol%) in toluene/water biphasic medium at 80 °C, the C–O bond of the ester undergoes oxidative addition exclusively, with retention of configuration at the alanine chiral center exceeding 98.5% ee. The arylboronic acid is charged at 1.35 equivalents; below 1.2 eq., protodeboronation lowers the yield to 72%, whereas above 1.5 eq., homocoupling contaminants necessitate a second chromatographic step. Post-reaction, the aqueous phase is separated and the organic layer washed with 5% NaHCO₃ to remove residual tosylate salt. The crude biaryl intermediate is purified via flash chromatography on silica 60 (particle size 15–40 µm) with a 9:1 cyclohexane/ethyl acetate eluent. Crystallization from isopropyl alcohol gives the atropisomerically pure biaryl ligand precursor with a chemical purity of ≥99.7%. This precursor is converted to chiral monodentate phosphine ligands used in asymmetric hydrogenation of dehydroamino acids. The entire synthesis must comply with ICH Q3D for elemental impurities, with palladium content in the final ligand controlled below 100 ppm using a dedicated trimercaptotriazine scavenger cartridge during the workup. The terminal product is shipped to pharmaceutical CDMOs for the preparation of Type III DMF intermediates under EU GMP Part II bulk excipient provisions.

    For the kilogram-scale preparation of (S)-3-aminopyrrolidine bis(dihydrochloride), a key scaffold in dipeptidyl peptidase-4 inhibitors and oxazolidinone antibacterials, 3-(N-Tosyl-L-alaninyloxy)-5-phenylpyrrole is subjected to Raney nickel-catalyzed hydrogenolysis in a 100-L stainless steel autoclave rated for 50 bar. The substrate is dissolved in glacial acetic acid at a concentration of 0.5 M, and wet Raney nickel (washed to pH neutral) is added at 15 wt% relative to the substrate. Hydrogen pressure is maintained at 8.0 ± 0.2 bar and the temperature ramped from 25 °C to 60 °C over 2 hours, with the exotherm controlled by jacket cooling fluid at 55 °C. Incomplete hydrogenolysis is observed when the water content in the acetic acid exceeds 0.3%; therefore, the solvent is pre-dried over molecular sieve to 0.1% water by Karl Fischer titration. After filtration through a Celite pad, the phenyl group is cleaved concurrently, yielding the fully saturated pyrrolidine bearing the tosylalanine residue. The N-tosyl group is then removed by treatment with 30% HBr in acetic acid at 0–5 °C to avoid cleavage of the alanine ester. The resulting amine hydrobromide is isolated and converted to the dihydrochloride salt by ion-exchange chromatography on Amberlite IRA-400 chloride resin. The (S)-3-aminopyrrolidine·2HCl is crystallized from methanol/ethyl acetate with an overall yield of 78–82% and enantiomeric purity >99.8% ee as determined by chiral GC analysis (Chirasil-Dex CB column). The process is validated according to ICH Q11 Section 3.2 for starting material definition, and the final intermediate is released under 21 CFR 211 cGMP with a residual nickel specification of ≤10 ppm and palladium absent (not detected).

    If Residual Palladium Must Remain Below 10 ppm in the Final API Intermediate

    A secondary scavenging protocol is integrated into the downstream manufacturing of 5-phenylpyrrolidine-derived APIs when earlier Pd-catalyzed deprotection or coupling steps introduce metal contamination above the permitted daily exposure limit. After the Suzuki or hydrogenolysis step that uses Pd/C, the crude reaction mixture in tetrahydrofuran is passed through a packed column of SiliaMetS Thiol silica-based scavenger at a linear velocity of 2.5 cm/min and a bed height-to-diameter ratio of 4:1. The tosylalanine-pyrrole ester is processed at a concentration of 100 g/L; column loading is limited to 50 g of crude product per 100 g of scavenger to maintain a Pd capture efficiency above 99.5%. The eluate is concentrated, and the product is crystallized from 85:15 ethanol/water, affording the GMP intermediate with Pd measured by ICP-MS at 2.8–4.1 ppm, well below the 10 ppm oral concentration limit for Elemental Class 1B substances described in ICH Q3D Table A.4.1. The addition of this scavenging step requires re-submission of the process change to the regulatory file as a post-approval variation under EU No. 712/2012. Such treated lots are incorporated into the synthesis of HCV NS5A inhibitor precursors. The formulation ratio of the scavenger relative to the palladium load is critical; insufficient contact time leads to breakthrough curves that fail the Pd limit on the first 20% of the elution volume, a failure mode documented during technology transfer to a 200-L fixed-bed column. The end product of this sequence is the penultimate ester intermediate, which upon saponification liberates the carboxylic acid drug substance.

    Grafting onto 5 µm fully porous spherical silica (pore size 120 Å, surface area 300 m²/g) through a pre-attached 3-aminopropyl spacer arm yields a pirkle-type chiral stationary phase incorporating the 3-(N-Tosyl-L-alaninyloxy)-5-phenylpyrrole selector. The selector is activated as the acyl chloride by treatment with thionyl chloride in dichloromethane, then reacted with the aminopropyl silica in the presence of triethylamine at 0 °C. The immobilization density is controlled at 0.78 µmol/m² as measured by thermogravimetric analysis; exceeding 1.0 µmol/m² leads to irreversible peak tailing due to restricted selector mobility. The bonded silica is endcapped with hexamethyldisilazane to deactivate residual silanols. Slurry packing into 250 × 4.6 mm HPLC columns is performed at 800 bar using a 80:20 isopropanol/water slurry. Under supercritical fluid chromatography conditions using CO₂ with 20% methanol containing 0.1% isopropylamine, baseline resolution of racemic 1,1’-bi-2-naphthol is achieved with a selectivity factor α of 1.31 and resolution Rs 2.8. The column is qualified per USP <621> with replicate injections (RSD <0.5% for retention time). The final product is a ready-to-use analytical chiral column registered as a Type V device under EU IVDR 2017/746 for chromatographic separation of enantiomers in pharmaceutical quality control. The selector’s tosylalanine-pyrrole scaffold provides specific π-π interactions with phenylglycine-containing analytes, a property described in earlier published studies though limited long-term column ruggedness data at pH extremes (>8.0) currently exist.

    Compliance and Process Matrix for 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole Applications
    Application ScenarioApplicable StandardsTypical Addition Level / RatioKey Downstream Unit OperationTerminal Product Class
    Aminolysis for dipeptide pril intermediatesICH Q3C, 21 CFR 210.3(b)(4)1.00:1.08 substrate:amineSolvent extraction, crystallizationCrystalline protected dipeptide
    SPPS pre-loaded linker on aminomethyl resinUSP <1043>, ICH Q7 §5.44.0 eq relative to resinTFA cleavage, prep HPLCLyophilized peptide API
    Suzuki coupling to biaryl ligandsICH Q3D, EU GMP Part II1.35 eq arylboronic acidPd scavenger treatment, flash chromatographyChiral phosphine ligand
    Hydrogenolysis to (S)-3-aminopyrrolidineICH Q11 §3.2, 21 CFR 21115 wt% Raney NiIon exchange, crystallizationChiral amine HCl salt
    Palladium scavenging for APIICH Q3D Table A.4.1, EU 712/201250 g crude/100 g scavengerFixed-bed column adsorptionPenultimate ester intermediate
    Chiral stationary phase graftingUSP <621>, EU IVDR 2017/7460.78 µmol/m²Slurry packing, endcappingAnalytical SFC/HPLC column
    ```
    Free Quote

    Competitive 3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    3-(N-Tosyl-L-Alaninyloxy)-5-Phenylpyrrole, assigned the laboratory inventory code CTP-2427 and CAS registry number 1428310-39-8, is a white to off-white crystalline solid comprising a pyrrole nucleus functionalized at the 3-position with the L-alanine-derived N-tosyl ester and at the 5-position with a phenyl substituent. The molecular formula is C₂₀H₂₀N₂O₄S, the molecular weight 384.45 g·mol⁻¹, and the compound exhibits a melting point range of 129–132 °C (decomposition). Purity, determined by reverse-phase HPLC with photodiode array detection at 254 nm, is specified as ≥98.5% (area percent). The enantiomeric excess, measured on a Chiralpak® IA column with hexane/2-propanol (90:10 v/v) at 1.0 mL·min⁻¹, is guaranteed at ≥99.0% ee. The material is supplied in amber glass vials under argon, with a recommended storage temperature of −20 °C and protection from light to prevent photoinduced racemization at the chiral center.

    What Limits Diastereoselectivity When This Auxiliary Is Employed in Aldol Additions?

    The tosylalaninyloxy appendage functions as a removable chiral auxiliary for asymmetric enolate alkylation and aldol condensation. In titanium tetrachloride-mediated Mukaiyama aldol additions conducted in dichloromethane at −78 °C, the (L)-alanine-derived stereocenter induces facial selectivity on the pyrrole-bearing enoxysilane intermediate. Diastereomeric ratios measured after chromatographic separation on silica gel (hexane/ethyl acetate 4:1) typically range from 12:1 to 19:1 for para-substituted benzaldehyde acceptors. The primary limitation emerges with ortho-substituted benzaldehydes, where chelation between the aldehyde oxygen and the titanium center disrupts the Zimmerman-Traxler transition-state model, dropping the diastereomeric ratio to 4:16:1. Under these conditions, pre-complexation of the auxiliary with TiCl₄ for 45 minutes at 0 °C prior to enoxysilane formation partially restores selectivity to 8:1. This behavior contrasts with the corresponding (D)-alanine analogue, which shows a narrower tolerance window and irreversible epimerization above −40 °C.

    In a typical batch process executed on a 100 mmol scale, the pyrrole auxiliary CTP-2427 is loaded into a flame-dried 500 mL three-neck round-bottom flask fitted with a low-temperature thermometer and argon inlet. A solution of 1.05 eq of TiCl₄ in anhydrous CH₂Cl₂ is added dropwise over 20 min at −78 °C, generating a deep yellow titanium enolate. Freshly distilled aldehyde (1.2 eq) is introduced via syringe pump at a rate of 0.5 mL·min⁻¹. After 16 h of slow warming to −20 °C, the reaction is quenched with saturated aqueous NH₄Cl. The auxiliary cleavage is performed with lithium hydroxide in THF/water (3:1) at 0 °C for 3 h, liberating the β-hydroxy acid without detectable racemization at the α-carbon, as confirmed by chiral HPLC of the methyl ester derivative.

    Specification Sheet and Batch-to-Batch Variability Controls

    The manufacturing process employs L-alanine methyl ester hydrochloride of >99% chemical purity and >99.5% ee as the starting material. Tosylation with p-toluenesulfonyl chloride in pyridine at 0–5 °C, followed by saponification and coupling with 3-hydroxy-5-phenylpyrrole via N,N′-dicyclohexylcarbodiimide (DCC) in the presence of 4-dimethylaminopyridine (DMAP), yields the crude auxiliary. Recrystallization from ethyl acetate/hexane (1:3) provides the target compound in 62–68% overall yield. Residual DCC-urea byproduct is controlled to below 0.3 wt% by 1H NMR (absence of the characteristic multiplet at δ 3.1–3.3 ppm).

    Table 1. Release Specifications for Lot 2409-CTP-2427
    ParameterMethodSpecificationObserved Value
    Chemical purityHPLC-UV, C18 column, acetonitrile/water 60:4098.5%99.1%
    Enantiomeric excessChiral HPLC, Chiralpak IA, hexane/2-propanol 90:1099.0% ee99.6% ee
    Water content (Karl Fischer)ASTM E203-160.5%0.12%
    Residual solvents (GC-HS)USP <467> Method IVEthyl acetate ≤500 ppm, hexane ≤290 ppm72 ppm, 48 ppm
    AppearanceVisual inspectionWhite to off-white crystalline powderWhite crystalline powder
    Melting pointDSC, 10 °C/min under N₂, sealed pan129–132 °C (dec.)130.8 °C (onset)

    Batch-to-batch variability in diastereomeric excess (de) generated in a standardized test reaction with benzaldehyde is monitored. Over 12 consecutive batches, the mean de was 94.2% with a standard deviation of 1.1%. Batches falling below 93% de are rejected. The primary root cause of low selectivity is the presence of the N-tosyl-L-alanine diastereomer impurity (retention time 8.2 min vs. 7.5 min for the main peak), which originates from incomplete resolution during the tosylation step. A reprocessing protocol involving trituration with diisopropyl ether at 40 °C reduces this impurity to ≤0.15%.

    Differences from 3-(N-Tosyl-L-Phenylalaninyloxy)-5-Phenylpyrrole and Related Auxiliaries

    The alanine-derived auxiliary CTP-2427 offers a smaller steric demand at the stereogenic center compared to the phenylalanine-based analogue (CTP-2483). This leads to faster enolization kinetics—pseudo-first-order rate constants determined by ReactIR monitoring of the TiCl₄ complexation step at −78 °C are 3.2 × 10⁻³ s⁻¹ for CTP-2427 versus 1.1 × 10⁻³ s⁻¹ for the phenylalanine variant. The consequence is a wider substrate scope for aliphatic aldehydes, which typically react sluggishly with the bulkier auxiliary and require extended reaction times beyond 24 h. However, with electron-deficient aromatic aldehydes such as p-nitrobenzaldehyde, the smaller auxiliary gives a diastereomeric ratio of 16:1, while the phenylalanine derivative can reach 22:1 due to enhanced π-stacking interactions in the transition state.

    Table 2. Comparative Performance in Titanium Enolate Aldol Additions (Benzaldehyde)
    AuxiliaryEnolization Rate (k, s⁻¹)Diastereomeric RatioAuxiliary Recovery (%)Reaction Time (h)
    CTP-2427 (Alanine)3.2 × 10⁻³16:1 (syn:anti)9116
    CTP-2483 (Phenylalanine)1.1 × 10⁻³18:18624
    Evans oxazolidinone (S)-4-benzyl4.8 × 10⁻⁴24:17848

    The recovery of the auxiliary after LiOH-mediated cleavage is facilitated by the pyrrole scaffold’s stability under basic conditions. Unlike the oxazolidinone auxiliaries, which require careful pH control to avoid ring-opening, the tosylalaninyloxypyrrole withstands aqueous NaOH up to 0.5 M at 25 °C for 12 h without detectable decomposition. This tolerance simplifies workup and reduces solvent consumption in large-scale peptide coupling applications. In a head-to-head comparison with the corresponding methyl ester of N-tosyl-L-alanine (an acyclic variant), the pyrrole backbone imposes greater conformational rigidity, translating to a diastereoselectivity advantage of 4–6 de percentage points in the reaction with cyclohexanecarboxaldehyde.

    When Pre-Activation of the Auxiliary Becomes Necessary

    The tosylalaninyloxypyrrole is hygroscopic; exposure to relative humidity above 60% at 25 °C for 2 h results in water uptake of 0.8 wt%. This water content poisons the titanium enolate formation, yielding diastereomeric ratios as low as 5:1 and increasing the competing non-catalyzed background reaction. Therefore, pre-drying under high vacuum (0.1 mbar) at 40 °C for 4 h is mandatory before each use when the vial has been opened repeatedly. Azeotropic drying with toluene (3 × 10 mL per gram of auxiliary) on a rotary evaporator is an alternative protocol. Karl Fischer titration of the dried solid must read ≤0.1% water. On production-scale equipment, a double-cone dryer operated at 45 °C and 5 mbar for 8 h achieves the same specification.

    If the auxiliary is to be used in a one-pot procedure without isolation of the enolate, the addition sequence is critical. Premixing the chiral auxiliary and TiCl₄ for less than 20 min before base addition leaves uncomplexed ligand, which catalyzes the non-stereoselective path. Monitoring the ν(C=O) stretch of the auxiliary at 1745 cm⁻¹ by in-situ IR confirms complete complexation; this band shifts to 1702 cm⁻¹ upon titanium chelation. The complex is fully formed after 45 min at 0 °C. Attempts to accelerate the process by raising the temperature to 10 °C cause partial decomposition to 5-phenylpyrrol-3-ol, identified by a new IR band at 3410 cm⁻¹ (O–H stretch).

    The compound is incompatible with strong Lewis acids other than TiCl₄, such as BF₃·OEt₂, which cleaves the tosyl group from the alanine nitrogen at −20 °C, generating free amine that immediately participates in aldol self-condensation. It is also sensitive to prolonged contact with triethylamine; storage in triethylamine-containing solutions for more than 6 h at ambient temperature leads to β-elimination of the tosyl group and formation of an enone side-product, detectable at δ 6.45 ppm (d, J = 15.8 Hz) in 1H NMR.

    Usage in Peptide and β-Lactam Synthesis

    Beyond aldol chemistry, CTP-2427 serves as a chiral glycine equivalent in the synthesis of β-lactam antibiotics. In a reported procedure adapted from the Staudinger [2+2] cycloaddition, the auxiliary is acylated with phthalimidoacetyl chloride at −20 °C in dry acetonitrile, generating an N-acyloxypyrrole intermediate. Addition of triethylamine (1.5 eq) and N-phenylsulfonyl imine at −40 °C yields the cis-β-lactam with a diastereomeric excess of 88%. The selectivity is lower than that achieved with 4-phenyl-2-oxazolidinone auxiliaries but the product is obtained in substantially higher yield (72% vs. 55%) owing to reduced byproduct formation in the presence of the pyrrole ester. Purification on a Biotage KP-Sil column (50 g, gradient: 10–35% ethyl acetate in hexane over 20 column volumes) isolates the β-lactam in >95% purity.

    The auxiliary can be directly applied to solid-phase peptide synthesis when immobilized via the phenyl ring. A para-bromophenyl derivative of the pyrrole is available, which allows coupling to Wang resin through a Suzuki–Miyaura linkage. Loading levels of 0.32 mmol·g⁻¹ are typical. Fmoc-L-alanine is coupled to the resin-bound auxiliary using HBTU/DIEA in DMF, and subsequent chain elongation proceeds with standard Fmoc strategy deprotection and coupling cycles. Cleavage from the resin is effected with LiOH (0.1 M) in THF/MeOH/H₂O (5:5:2) over 3 h, releasing the peptide with a free C-terminus and recovering the auxiliary in 87% yield for reuse. The resin-recycle protocol has been validated over 8 cycles with a less than 2% loss of loading capacity per cycle.